APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy - PubMed (original) (raw)
. 2006 Nov;129(Pt 11):2977-83.
doi: 10.1093/brain/awl203. Epub 2006 Aug 18.
Affiliations
- PMID: 16921174
- DOI: 10.1093/brain/awl203
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy
Kristel Sleegers et al. Brain. 2006 Nov.
Abstract
We assessed the impact of amyloid precursor protein (APP) gene locus duplications in early onset Alzheimer's disease in a Dutch population-based sample. Using real-time PCR and an in-house-developed multiplex amplicon quantification assay, we identified a genomic APP duplication in 1 out of 10 multigenerational families segregating early onset Alzheimer's disease. In this family, cerebral amyloid angiopathy (CAA) coincided with this disease. The duplicated genomic region included no other genes than APP and extended maximally over 0.7 Mb. In a sample of 65 familial early onset patients, we observed the same APP genomic duplication in one patient (1.7%), while in 36 isolated patients duplications in the APP locus were absent. This indicated that APP locus duplications explained <2% of familial, non-autosomal dominant Alzheimer's disease and are an infrequent cause of de novo mutation. Our findings corroborated a recent French study, and indicated that investigating genomic duplications in the APP locus in families segregating Alzheimer's disease and CAA should be considered.
Similar articles
- Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
Blom ES, Viswanathan J, Kilander L, Helisalmi S, Soininen H, Lannfelt L, Ingelsson M, Glaser A, Hiltunen M. Blom ES, et al. Eur J Hum Genet. 2008 Feb;16(2):171-5. doi: 10.1038/sj.ejhg.5201966. Epub 2007 Nov 28. Eur J Hum Genet. 2008. PMID: 18043715 - APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.
Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerrière A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D. Rovelet-Lecrux A, et al. Nat Genet. 2006 Jan;38(1):24-6. doi: 10.1038/ng1718. Epub 2005 Dec 20. Nat Genet. 2006. PMID: 16369530 - Phenotype associated with APP duplication in five families.
Cabrejo L, Guyant-Maréchal L, Laquerrière A, Vercelletto M, De la Fournière F, Thomas-Antérion C, Verny C, Letournel F, Pasquier F, Vital A, Checler F, Frebourg T, Campion D, Hannequin D. Cabrejo L, et al. Brain. 2006 Nov;129(Pt 11):2966-76. doi: 10.1093/brain/awl237. Epub 2006 Sep 7. Brain. 2006. PMID: 16959815 - [From gene to disease; amyloid-beta precursor protein gene instrumental in hereditary cerebral amyloid angiopathies].
Haan J, Bakker E, Bornebroek M, Roos RA. Haan J, et al. Ned Tijdschr Geneeskd. 2001 Aug 25;145(34):1639-41. Ned Tijdschr Geneeskd. 2001. PMID: 11552366 Review. Dutch. - [Genetic factors for cerebral amyloid angiopathy].
Hamaguchi T, Yamada M. Hamaguchi T, et al. Brain Nerve. 2008 Nov;60(11):1275-83. Brain Nerve. 2008. PMID: 19069161 Review. Japanese.
Cited by
- Does Dementia Have a Microbial Cause?
Landry RL, Embers ME. Landry RL, et al. NeuroSci. 2022 May 17;3(2):262-283. doi: 10.3390/neurosci3020019. eCollection 2022 Jun. NeuroSci. 2022. PMID: 39483362 Free PMC article. Review. - Structural variants linked to Alzheimer's Disease and other common age-related clinical and neuropathologic traits.
Vialle RA, de Paiva Lopes K, Li Y, Ng B, Schneider JA, Buchman AS, Wang Y, Farfel JM, Barnes LL, Wingo AP, Wingo TS, Seyfried NT, De Jager PL, Gaiteri C, Tasaki S, Bennett DA. Vialle RA, et al. medRxiv [Preprint]. 2024 Aug 13:2024.08.12.24311887. doi: 10.1101/2024.08.12.24311887. medRxiv. 2024. PMID: 39185527 Free PMC article. Preprint. - Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
Kasri A, Camporesi E, Gkanatsiou E, Boluda S, Brinkmalm G, Stimmer L, Ge J, Hanrieder J, Villain N, Duyckaerts C, Vermeiren Y, Pape SE, Nicolas G, Laquerrière A, De Deyn PP, Wallon D, Blennow K, Strydom A, Zetterberg H, Potier MC. Kasri A, et al. Acta Neuropathol. 2024 Jul 18;148(1):8. doi: 10.1007/s00401-024-02756-4. Acta Neuropathol. 2024. PMID: 39026031 Free PMC article. - A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease.
Galasko D, Farlow MR, Lucey BP, Honig LS, Elbert D, Bateman R, Momper J, Thomas RG, Rissman RA, Pa J, Aslanyan V, Balasubramanian A, West T, Maccecchini M, Feldman HH. Galasko D, et al. Alzheimers Res Ther. 2024 Jul 5;16(1):151. doi: 10.1186/s13195-024-01490-z. Alzheimers Res Ther. 2024. PMID: 38970127 Free PMC article. Clinical Trial. - Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.
Ghosh U, Tse E, Yang H, Shi M, Caro CD, Wang F, Merz GE, Prusiner SB, Southworth DR, Condello C. Ghosh U, et al. Acta Neuropathol Commun. 2024 Jun 12;12(1):94. doi: 10.1186/s40478-024-01806-y. Acta Neuropathol Commun. 2024. PMID: 38867338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous